3,4-Methylenedioxymethamphetamine (MDMA) enhances the release of acetylcholine by 5-HT4 and D1 receptor mechanisms in the rat prefrontal cortex

Synapse

Volumn 58, Issue 4, 2005, Pages 229-235

  Nair, Unila G ^a   Gudelsky, Gary A ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Dopamine (DA); LY 53,857; Microdialysis; SCH 23390; SDZ 205,557; Serotonin (5 HT)

Indexed keywords

1 ISOPROPYL 6 METHYLERGOLINE 8 CARBOXYLIC ACID 2 HYDROXY 1 METHYLPROPYL ESTER; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; 4 AMINO 5 CHLORO 2 METHOXYBENZOIC ACID 2 (DIETHYLAMINO)ETHYL ESTER; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ACETYLCHOLINE; AMPHETAMINE DERIVATIVE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR BLOCKING AGENT; RECEPTOR SUBTYPE; SEROTONIN 2 ANTAGONIST; SEROTONIN 2A ANTAGONIST; SEROTONIN 2B RECEPTOR ANTAGONIST; SEROTONIN 2C ANTAGONIST; SEROTONIN 4 ANTAGONIST; SEROTONIN 4 RECEPTOR; UNCLASSIFIED DRUG;

ACETYLCHOLINE RELEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENANTIOMER; MALE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT;

4-AMINOBENZOIC ACID; ACETYLCHOLINE; ANIMALS; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ERGOLINES; HALLUCINOGENS; MALE; MICRODIALYSIS; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RECEPTORS, SEROTONIN, 5-HT4; SEROTONIN ANTAGONISTS;

EID: 28044449923     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/syn.20202     Document Type: Article

References (54)

1. 1-receptor mediated increases in acetylcholine release in rat frontal cortex. Psychopharmacology (Berl) 125:162-167.
2. Acquas E, Morrocu P, Pisanu A, Cadoni C, Zernig G, Saria A, DiChiara G. 2001. Intravenous administration of ecstasy (3,4-methylenedioxymethamphetamine) enhances cortical and striatal acetylcholine release. Eur J Pharmacol 418:207-211.
3. Andersen PH, Gronvald FC, Hohlweg R, Hansen LB, Guddal E, Braestrup C, Nielsen EB. 1992. NNC-112, NNC-687 and NNC-756, new selective and highly potent dopamine D1 receptor antagonists. Eur J Pharmacol 219:45-52.
4. Battaglia G, Brooks BP, Kulsakdinun C, De Souza EB. 1988. Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sites. Eur J Pharmacol 149: 159-163.
5. Boess FG, Martin IL. 1994. Molecular biology of 5-HT receptors. Neuropharmacol 33:275-317.
6. 4 receptor stimulation facilitates acetylcholine release in rat frontal cortex. Neuroreport 5:1230-1232.
7. 1B receptors. J Pharmacol Exp Ther 277:823-830.
8. 1 receptor stimulation increases striatal acetylcholine release in the rat. Eur J Pharmacol 186:335-338.
9. 1 and NMDA receptors. J Pharmacol Exp Ther 259:1064-1072.
10. Darvesh AS, Shankaran M, Gudelsky GA. 2002. 3,4- Methylenedioxymethamphetamine produces glycogenolysis and increases the extracellular concentration of glucose in the rat brain. J Pharmacol Exp Ther 301:138-144.
11. Day J, Fibiger HC. 1992. Dopaminergic regulation of cortical acetylcholine release. Synapse 12:281-286.
12. Day JC, Chui-Se T, Fibiger HC. 1994. Dopamine depletion attenuates amphetamine-induced increases of cortical acetylcholine release. Eur J Pharmacol 263:285-292.
13. 2 dopamine receptor subtypes. J Pharmacol Exp Ther 277:775-783.
14. Fantegrossi WE, Godlewski T, Karabenick RL, Stephens JM, Ullrich T, Rice KC, Woods JH. 2003. Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine ("ecstasy") and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice. Psychopharmacology (Berl) 166:202-211.
15. Fisher HS, Zernig G, Schatz DS, Humpel C, Saria A. 2000. MDMA (ecstasy) enhances basal acetylcholine release in brain slices of the rat striatum. Eur J Neurosci 12:1385-1390.
16. Giovannini MG, Ceccarelli I, Molinari B, Cecchi M, Goldfarb J, Blandina P. 1998. Serotonergic modulation of acetylcholine release from cortex of freely moving rats. J Pharmacol Exp Ther 285: 1219-1225.
17. Gough B, Ali SF, Slikker W, Jr., Holson RR. 1991. Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on monoamines in the rat caudate. Pharmacol Biochem Behav 39:619-623.
18. 2 receptor agonists. Eur J Pharmacol 264:325-330.
19. 2A receptor in the hyperlocomotive and hyperthermic effects of (+)-3,4-methylenedioxymethamphetamine. Psychopharmacology (Berl) 178:505-513.
20. 1 receptors: a combined receptor autoradiography and in vivo dialysis study. J Neurosci 15:7150-7157.
21. Hiramatsu M, Cho AK. 1990. Enantiomeric differences in the effects of 3,4-methylenedioxymethamphetamine on extracellular monoamines and metabolites in the striatum of freely-moving rats: an in vivo microdialysis study. Neuropharmacology 29:269-275.
22. Hiramatsu M, Nabeshima T, Kameyama T, Maeda Y, Cho AK. 1989. The effect of optical isomers of 3,4-methylenedioxymethamphetamine (MDMA) on stereotyped behavior in rats. Pharmacol Biochem Behav 33:343-347.
23. Hirano H, Day J, Fibiger HC. 1995. Serotonergic regulation of acetylcholine release in rat frontal cortex. J Neurochem 65:1139-1145.
24. Imperato A, Obinu MC, Gessa GL. 1993. Effects of cocaine and amphetamine on acetylcholine release in the hippocampus and caudate nucleus. Eur J Pharmacol 238:377-381.
25. 3H] dopamine release from superfused rat brain slices. Eur J Pharmacol 132:269-276.
26. Jones BE, Cuello AC. 1989. Afferents to the basal forebrain cholinergic cell area from the pontomesencephalic catecholamine, serotonin and acetylcholine neurons. Neuroscience 31:37-61.
27. 1A receptor-mediated pathways by BAY × 3702 in freely moving rats. Neurosci Lett 265:33-36.
28. Liechti ME, Saur MR, Gamma A, Hell D, Vollenweider FX. 2000. Psychological and physiological effects of MDMA ("ecstasy") after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humans. Neuropsychopharmacology 23:396-404.
29. 2 receptors Psychopharmacology (Berl) 88:525-526.
30. McGuire PK, Cope H, Fahy TA. 1994. Diversity of psychopathology associated with use of 3,4-methylenedioxymethamphetamine ('Ecstasy'). Br J Psychiatry 165:391-395.
31. McMahon LR, Cunningham KA. 1999. Antagonism of 5-hydroxytryptamine (4) receptors attenuates hyperactivity induced by cocaine: putative role for 5-hydroxytryptamine(4) receptors in the nucleus accumbens shell. J Pharmacol Exp Ther 291:300-307.
32. Moore H, Fadel J, Sarter M, Bruno JP. 1999. Role of accumbens and cortical dopamine receptors in the regulation of cortical acetylcholine release. Neuroscience 88:811-822.
33. 2 receptors enhances the release of acetylcholine in the prefrontal cortex and hippocampus of the rat. Synapse 53:202-207.
34. Nash JF. 1990. Ketanserin pretreatment attenuates MDMA-induced dopamine release in the striatum as measured by in vivo microdialysis. Life Sci 47:2401-2408.
35. Nash JF, Brodkin J. 1991. Microdialysis studies on 3,4- methylenedioxymethamphetamine-induced dopamine release: effect of dopamine-uptake inhibitors. J Pharmacol Exp Ther 259:820-825.
36. Nash JF, Jr., Meltzer HY, Gudelsky GA. 1988. Elevation of serum prolactin and corticosterone concentrations in the rat after the administration of 3,4-methylenedioxymethamphetamine. J Pharmacol Exp Ther 245:873-879.
37. Nelson DL, Lucaites VL, Audia JE, Nissen JS, Wainscott DB. 1993. Species differences in the pharmacology of the 5-hydroxytryptamine2 receptor: structurally specific differentiation by ergolines and tryptamines. J Pharmacol Exp Ther 265:1272-1279.
38. O'Shea E, Granados R, Esteban B, Colado MI, Green AR. 1998. The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA ('ecstasy'). Neuropharmacology 37:919-926.
39. Paxinos G, Watson C. 1986. The rat brain in stereotaxic coordinates. San Diego, CA: Academic Press.
40. Peroutka SJ, Newman H, Harris H. 1988. Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users. Neuropsychopharmacology 1:273-277.
41. Ricaurte GA, Yuan J, McCann UD. 2000. (+/-)3,4- Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: studies in animals. Neuropsychobiology 42:5-10.
42. Rosecrans JA, Glennon RA. 1987. The effect of MDA and MDMA ("Ecstasy") isomers in combination with pirenpirone on operant responding in mice. Pharmacol Biochem Behav 28:39-42.
43. Sarter M, Bruno JP. 1999. Abnormal regulation of corticopetal cholinergic neurons and impaired information processing in neuropsychiatric disorders. Trends Neurosci 22:67-74.
44. Schmidt CJ, Abbate GM, Black CK, Taylor VL. 1990a. Selective 5-hydroxytryptamine2 receptor antagonists protect against the neurotoxicity of methylenedioxymethamphetamine in rats. J Pharmacol Exp Ther 255:478-483.
45. 2 receptors. Brain Res 529: 85-90.
46. Schmidt CJ, Black CK, Taylor VL. 1990c. Antagonism of the neurotoxicity due to a single administration of methylenedioxymethamphetamine. Eur J Pharmacol 181:59-70.
47. Steele TD, Nichols DE, Yim GK. 1987. Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain. Biochem Pharmacol 36:2297-2303.
48. Svenningsson P, Tzavara ET, Liu F, Fienberg AA, Nomikos GG, Greengard P. 2002. DARPP-32 mediates serotonergic neurotransmission in the forebrain. Proc Natl Acad Sci USA 99:3188-3193.
49. 2 receptors in rat medial prefrontal cortex. J Neurosci 13:2551-2564.
50. 4 binding sites in rat brain. Behav Brain Res 73:259-262.
51. 4 receptor involvement in the enhancement of acetylcholine release by p-chloroamphetamine in rat frontal cortex. Brain Res 772:95-101.
52. 4 receptors. Naunyn Schmiedebergs Arch Pharmacol 356:712-720.
53. Yamamoto BK, Spanos LJ. 1988. The acute effects of methylenedioxymethamphetamine on dopamine release in the awake-behaving rat. Eur J Pharmacol 148:195-203.
54. Zaborszky, L. 1989. Afferent connections of the forebrain cholinergic projection neurons, with special reference to monoaminergic and peptidergic fibres. In: Frotscher M, Misgeld U, editors. Central Cholinergic Synaptic Transmission. Basel: Birkhauser p 12-32.